tradingkey.logo
tradingkey.logo

Lantheus Announces Three-Month Extension Of PDUFA Date For LNTH-2501

ReutersMar 17, 2026 8:26 PM

- Lantheus Holdings Inc LNTH.O:

  • LANTHEUS ANNOUNCES THREE-MONTH EXTENSION OF PDUFA DATE FOR LNTH-2501 (GA 68 EDOTREOTIDE), A PET DIAGNOSTIC IMAGING KIT TARGETING SOMATOSTATIN RECEPTOR-POSITIVE (SSTR+) NEUROENDOCRINE TUMORS (NETS)

  • LANTHEUS HOLDINGS INC - STANDARD REVIEW EXTENSION FOR LNTH-2501 NOT RELATED TO EFFICACY OR SAFETY DATA

  • LANTHEUS HOLDINGS INC - FDA EXTENDS REVIEW OF LNTH-2501 NDA TO JUNE 29, 2026

  • LANTHEUS HOLDINGS INC - FDA EXTENDS PDUFA GOAL DATE FOR LNTH-2501 TO JUNE 29, 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI